These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 628018)
1. Focal suppression and induction of hyperplasia by the bladder carcinogens butyl(4-hydroxybutyl)nitrosamine and buty(3-carboxypropyl)nitrosamine in organ-cultured rat bladder epithelium. Reese DH; Friedman RD; Gaffield W; Keefer LK J Natl Cancer Inst; 1978 Jan; 60(1):219-23. PubMed ID: 628018 [TBL] [Abstract][Full Text] [Related]
2. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine. Hirose M; Murasaki G; Imaida K; Fukushima S; Ito N Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722 [TBL] [Abstract][Full Text] [Related]
3. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039 [TBL] [Abstract][Full Text] [Related]
4. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Lina BA; Woutersen RA Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752 [TBL] [Abstract][Full Text] [Related]
5. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats. Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745 [TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat. Suzuki E; Okada M Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630 [TBL] [Abstract][Full Text] [Related]
7. Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Zhang XH; Jin L; Takenaka I Urol Res; 1996; 24(5):279-83. PubMed ID: 8931292 [TBL] [Abstract][Full Text] [Related]
8. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice. Irving CC; Murphy WM; Daniel DS J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay. Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239 [TBL] [Abstract][Full Text] [Related]
10. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder. Suzuki E; Aoki J; Okada M Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666 [TBL] [Abstract][Full Text] [Related]
11. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233 [TBL] [Abstract][Full Text] [Related]
12. Effects of intravesical instillation of antitumor chemotherapeutic and immunotherapeutic agents on bladder lesion development in rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Okamura T; Ohtani M; Inoue K; Fukushima S; Ohtaguro K; Kakizoe T J Urol; 1987 Nov; 138(5):1305-7. PubMed ID: 2444722 [TBL] [Abstract][Full Text] [Related]
13. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Hirose M; Fukushima S; Hananouchi M; Shirai T; Ogiso T Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550 [TBL] [Abstract][Full Text] [Related]
14. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Suzuki E; Anjo T; Aoki J; Okada M Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438 [TBL] [Abstract][Full Text] [Related]
15. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat. Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665 [TBL] [Abstract][Full Text] [Related]
16. Concanavalin A agglutination of bladder cells of rats treated with bladder carcinogens; a rapid new test to detect bladder carcinogens. Kakizoe T; Kawachi T; Okada M Cancer Lett; 1978 Nov; 5(5):285-90. PubMed ID: 728886 [TBL] [Abstract][Full Text] [Related]
17. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Frolov AG; Pliss GB Vopr Onkol; 1992; 38(11):1309-13. PubMed ID: 1343160 [TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats. Okada M; Suzuki E; Hashimoto Y Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321 [TBL] [Abstract][Full Text] [Related]
19. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine. Tamano S; Shirai T; Kawabe M; Ni-I H; Mori Y; Okada M; Fukushima S Toxicol Pathol; 1992; 20(2):205-11. PubMed ID: 1475581 [TBL] [Abstract][Full Text] [Related]
20. [Structure and metabolic fate of N-nitrosodialkylamines in relation to their organotropic carcinogenicity with special reference to induction of urinary bladder tumors]. Mochizuki M; Suzuki E; Okada M Yakugaku Zasshi; 1997 Nov; 117(10-11):884-94. PubMed ID: 9414598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]